Fatemeh Masropour

Combination treatment with radiotherapy and a novel oxidative phosphorylation inhibitor overcomes PD-1 resistance and enhances antitumor immunity

J. Welsh, M. Davies, J. Marszalek, 2020, Journal for immunotherapy of cancer.

SHP-2 and PD-L1 Inhibition Combined with Radiotherapy Enhances Systemic Antitumor Effects in an Anti–PD-1–Resistant Model of Non–Small Cell Lung Cancer

J. Welsh, M. Cortez, V. Verma, 2020, Cancer Immunology Research.